Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lawrence Leo Martin is active.

Publication


Featured researches published by Lawrence Leo Martin.


European Journal of Pharmacology | 1992

Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents

Robert W. Dunn; Denise Mary Flanagan; Lawrence Leo Martin; Lisa L. Kerman; Anne T. Woods; Fernando Camacho; Carole A. Wilmot; Michael Cornfeldt; Richard C. Effland; Paul L. Wood; Roy Corbett

Anxiolytic agents disinhibit suppressed behaviors in rodents in preclinical models of anxiety such as the non-conditioned social interaction and elevated plus maze assays and the conditioned conflict Cook and Davidson procedure. The (+) and (-) enantiomers of (+/-)-3-amino-1-hydroxy-2-pyrrolidinone (HA-966) have been resolved and revealed that R-(+)-HA-966 significantly disinhibits both non-conditioned and conditioned suppressed behavior similar to the benzodiazepine diazepam, while the S-(-) enantiomer was devoid of anxiolytic activity and only produced behavioral sedation. Furthermore, R-(+)-HA-966 lacked side-effects in rodents commonly associated with the administration of benzodiazepines such as motor incoordination and ataxia, significant interactions with ethanol, and amnesia. These data suggest that R-(+)-HA-966, an antagonist at the strychnine-insensitive glycine/NMDA receptor site, was anxioselective and lacked some of the side-effects associated with benzodiazepine anxiolytics.


Bioorganic & Medicinal Chemistry Letters | 1997

Synthesis and preliminary structure-activity relationships of 1-[(3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate (P10358), a novel acetylcholinesterase inhibitor

Lawrence Leo Martin; Larry Davis; Joseph Thomas Klein; Peter Allen Nemoto; Gordon Edward Olsen; Gina M. Bores; Fernando Camacho; Wayne W. Petko; Douglas K. Rush; David E. Selk; Craig P. Smith; Hugo M. Vargas; James T. Winslow; Richard Charles Effland; David M. Fink

Abstract A series of carbamate analogs of besipirdine (HP 749) was synthesized as potential agents with enhanced cholinomimetic properties for the treatment of Alzheimers disease. Compound 5a (P10358, 1-[3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate) emerged as a potent, reversible acetylcholinesterase inhibitor that significantly enhanced performance on oral or parenteral administration in learning and memory paradigms.


Drug Development Research | 1998

4-aminopyridine derivatives: A family of novel modulators of voltage-dependent sodium channels

Lei Tang; Francis P. Huger; Joseph Thomas Klein; Larry Davis; Lawrence Leo Martin; Stephen Shimshock; Richard Charles Effland; Craig P. Smith; Sathapana Kongsamut

The interactions of a family of aminopyridine derivatives with Site II of the voltage‐dependent sodium channel were examined by measuring the ability of these compounds to inhibit [3H]batrachotoxin binding and veratridine‐induced increases in [Ca2+]i. Aminopyridines substituted with indole, carbazole, and pyrrole rings were evaluated. All compounds that had an aromatic ring linked to the amine group of 4‐aminopyridine showed positive results in both assays. For example, the most potent compound, besipirdine (N‐(n‐propyl)‐N‐(4‐pyridinyl)‐1H‐indol‐1‐amine), had IC50 values of 5 μM and 23.8 μM in the two assays, respectively. Small substitutions on either the aromatic ring or on 4‐aminopyridine did not substantially change their potencies. Indoles linked to the amino group of 2‐ and 3‐aminopyridine also showed positive results. These results indicate that aminopyridine derivatives substituted with an aromatic ring on the amino nitrogen are inhibitors of voltage‐dependent sodium channels. Drug Dev. Res. 44:8–13, 1998.


European Journal of Pharmacology | 1970

Toxicity of acids and bases after intraperitoneal injection.

Lawrence Leo Martin; Aaron H. Anton

Abstract Acetic acid, injected intraperitoneally, was lethal for mice housed in an incubator (37°C) and in the cold room (5°C), but not at room temperature (23°C). A dose of 4 meq/kg killed over 50% of the mice within 4 hr at the extremes of temperature, and none at 23°C. This difference in mortality was also obtained with other irritating acids and bases at the same dose, but not their salts. This effect was dose dependent with respect to the milliequivalency of injected agent. The cause of death is unknown. Poikilothermia was induced with the lethal agents at all 3 temperatures. Pretreatment of the mice with various pharmacologic agents did not prevent death. Autopsy of animals sacrificed just prior to death revealed necrosis of the mucosa and a peritoneal exudate in acid-treated animals; this pathology was judged identical at 23°C and 37°C with the same dose of acid. This pattern of mortality and poikilothermia resembles that obtained with endotoxin in mice, and may provide a simple, reproducible model for studying “endotoxic” death in mice, as well as its possible pharmacologic prevention.


Journal of Medicinal Chemistry | 1996

Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.

Joseph Thomas Klein; Larry Davis; Gordon Edward Olsen; George S. Wong; Francis P. Huger; Craig P. Smith; Wayne W. Petko; Michael Cornfeldt; J. C. Wilker; R. D. Blitzer; E. Landau; Vahram Haroutunian; Lawrence Leo Martin; Richard Charles Effland


Journal of Medicinal Chemistry | 1996

Dibenzoxepinone Hydroxylamines and Hydroxamic Acids: Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase with Potent Topical Antiinflammatory Activity

R. Richard L. Hamer; John J. Tegeler; Ellen S. Kurtz; Richard C. Allen; Steven C. Bailey; Mary Ellen Elliott; Luther Hellyer; Grover C. Helsley; Penelope Przekop; Brian S. Freed; John Kenneth White; Lawrence Leo Martin


Archive | 1992

Substituted (pyridinylamino)-indoles

Richard Charles Effland; Joseph Thomas Klein; Lawrence Leo Martin; Gregory Michael Shutske; Kevin J. Kapples; John Dick Tomer


Archive | 1991

4-heteroaryl-1,3-benzodiazepines and 2-substituted-gamma-(heteroaryl)benzeneethanamines

Lawrence Leo Martin; Joseph Francis Payack; Salvatore Brucato


Archive | 1992

Substituted 3-(pyridinylamino)-indoles and benzo¬b|thiophenes, a process for their preparation and their use as medicaments

Richard Charles Effland; Joseph Thomas Klein; Lawrence Leo Martin


Archive | 1993

(1H-Indol-1-yl)-2-(amino)acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, intermediates and a process for their preparation and their use as medicaments

Raymond W. Kosley; Denise Mary Flanagan; Lawrence Leo Martin; Peter Allen Nemoto

Collaboration


Dive into the Lawrence Leo Martin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph Thomas Klein

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge